Innovative design and implementation of next-generation Point-of-Care

01 January 2023 → 31 December 2026
European funding: framework programme
Research disciplines
  • Engineering and technology
    • Molecular and cellular biomechanics
T-cel therapy
Other information
Project description

There is a way to get immune cells to fight cancer. Chimeric antigen receptor (CAR) T-cell therapy collects the T cells from the patient and makes a small change to the cells. These specially altered T cells fight cancer. In this context, the Marie Skłodowska-Curie Actions project InnoCAR-T will provide training and carry out breakthrough research to develop next-generation CAR-T therapy. Specifically, the project will develop innovative manufacturing solutions for CAR-T production. It will also develop the next generation of more effective CAR-Ts. The project is designed to assist young scientists in generating breakthrough ideas in immunology, CAR engineering and gene editing.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Union nor the authority can be held responsible for them.